Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
curcumin (2 trials)
Cognitive Dysfunction (Phase 2)
Mental Disorders (Phase 2)
Psychotic Disorders (Phase 2)
Schizophrenia (Phase 2)
Trials (2 total)
Trial APIs (1 total)